Related Experiment Video
Updated: Jan 13, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Integrated Expression Analysis May Support Serine/Threonine Kinases as Common Hub Genes in Breast Cancer
Mohammad Soleiman Ekhtiyari1, Mostafa Ghaderi-Zefrehei2, Zahra Mogharari3
1Division of Biochemistry, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Five key breast cancer genes (NEK2, MELK, PLK1, AURKB, CHEK1) were identified as potential therapeutic targets. Higher expression of these genes correlates with poorer patient survival, highlighting their role in breast cancer progression.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Breast cancer (BC) is a leading cause of cancer-related deaths in women globally.
- Identifying novel molecular targets is crucial for developing effective BC therapies.
Purpose of the Study:
- To conduct a large-scale transcriptomic analysis to identify key genes involved in breast cancer pathophysiology.
- To identify potential therapeutic targets for breast cancer treatment.
Main Methods:
- Utilized transcriptomic data from NCBI GEO and TCGA databases (microarray and RNA-Seq).
- Identified differentially expressed genes (DEGs) and constructed gene co-expression networks using WGCNA.
- Identified hub genes using STRING and MCODE, followed by Gene Ontology enrichment analysis.
Main Results:
- Identified two regulatory modules, one with 85 genes in cancer and another with 474 genes in control tissues.
- Discovered a cluster of 29 cancer-related genes, including five hub genes: NEK2, MELK, PLK1, AURKB, and CHEK1.
- Found that elevated expression of these five hub genes is associated with decreased overall survival in breast cancer patients (P<0.001), with Hazard Ratios ranging from 1.41 to 1.77.
Conclusions:
- The identified hub genes (NEK2, MELK, PLK1, AURKB, CHEK1) are significantly associated with poorer patient survival in breast cancer.
- These genes play a critical role in breast cancer pathophysiology and represent potential targets for monitoring and therapeutic intervention.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

